Coach vs. Kors: Bat...
Health Care: Drugs
Discovery Laboratories Inc. (DSCO: NASDAQ)
$2.50 -0.02 | -0.79%
06/04/12 - 09:34 AM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| DSCO | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -26.33 | 2.86 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -0.87 | -0.49 | |
| Net Income | -0.46 | 0.00 | |
| EPS | -0.85 | 0.00 |
Earnings for DSCO:
| EBITDA | -23.00 |
| REVENUE | 582.00K |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $-0.21 | $-0.20 | $-0.91 | $-0.45 |
| Number of Analysts | 1 | 1 | 1 | 1 |
| High Estimate | $-0.21 | $-0.20 | $-0.91 | $-0.45 |
| Low Estimate | $-0.21 | $-0.20 | $-0.91 | $-0.45 |
| Prior Year | $-0.34 | $-0.26 | $-1.08 | $-0.91 |
| Growth Rate (Year over Year) | 38.24% | 23.08% | 15.74% | 50.55% |
Portfolios with DSCO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- UserSmall Cap Stocks
- UserKJP Spring Break
- Userjet189 Portfolio 1
- Uservolume spike
- Usermoon_in_mood Portfolio 1
- UserDtech Portfolio 1
- UserLizann
- UserBNunnally Portfolio 1
- Usershaldar Portfolio 1
Latest DSCO Headlines from TheStreet
- 5 Stocks Under $10 Poised for Upside 04.27.12 | 11:04 am
- For Biotech Takeovers, Timing is Key 04.04.12 | 06:04 am
- For Biotech, 'Fail' is Making a Big Comeback 03.12.12 | 08:03 am
- Biotech Stock Mailbag: Oncothyreon, Amag, Keryx Hate Mail 03.09.12 | 05:03 am
- Market Preview: The Bulls Finally Blink (Correct) 03.06.12 | 10:03 pm
- Pandora, Discovery Labs: After-Hours Trading (Update 1) 03.06.12 | 08:03 pm
- The Next Big Thing in Biotech: Discovery Labs
03.02.12 | 06:03 am - Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash 03.02.12 | 05:03 am
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
Press Releases for DSCO
- Pharmacoeconomic Analysis Shows SURFAXIN® May Reduce Hospital Cost Associated With Reintubation In Premature Infants - PR Newswire 05.01.12 | 07:05 am
- Media Alert: Discovery Labs To Hold Conference Call To Discuss FDA Approval Of SURFAXIN® (lucinactant) - PR Newswire 03.07.12 | 07:03 am
- Discovery Labs Announces FDA Approval Of SURFAXIN® (lucinactant) For Prevention Of Respiratory Distress Syndrome - PR Newswire 03.06.12 | 04:03 pm
- Discovery Labs Signs Manufacturing Agreement For AFECTAIR® - PR Newswire 02.08.12 | 07:02 am
- Discovery Labs Cleared To Market AFECTAIR In U.S. - PR Newswire 02.02.12 | 07:02 am
- New Study Shows AFECTAIR® Significantly Improved Delivery Of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions - PR Newswire 12.06.11 | 08:12 am
- Discovery Labs Releases New AFECTAIR⢠Performance Data Presented At The American Association For Respiratory Care Annual Meeting - PR Newswire 11.08.11 | 08:11 am
- New Study Shows Neonatologists And Parents Of NICU Infants Share Concern Regarding Newborn Exposure To Animal-Derived Medications - PR Newswire 10.18.11 | 07:10 am
- Discovery Labs Notified Of PDUFA Date For SURFAXIN® - PR Newswire 09.28.11 | 12:09 pm
- Discovery Labs Submits SURFAXIN® Complete Response To FDA - PR Newswire 09.06.11 | 07:09 am
Partner Headlines for DSCO
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Bio-Pharma Drug Approval Watch List: Final Results Plus One To Watch - Seeking Alpha 03.30.12 | 09:03 am
- Discovery Labs Down 17% After Public Offering Announcement - Benzinga 03.16.12 | 09:03 am
- Company News for March 8, 2012 - Corporate Summary - Zacks 03.08.12 | 10:03 am
- Discovery Labs Up 33% After Surfaxin Approved by the FDA - Benzinga 03.07.12 | 09:03 am
- Discovery Labs Announces FDA Approval of SURFAXIN for Prevention of Respiratory Distress Syndrome - Benzinga 03.06.12 | 04:03 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.15.11 | 09:11 am
- UPDATE 1-Discovery Labs' cystic fibrosis drug gets orphan status - Reuters 11.01.10 | 08:11 am
- UPDATE 1-Discovery Labs lung drug disappoints in mid-stage trial - Reuters 06.09.10 | 08:06 am
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
